| Financial Year |
March 31 2023 |
| Monetary Funds |
827,820,884.43 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
221,220,570.20 |
| Accounts Receivable |
1,116,602,485.33 |
| Advances to Suppliers |
87,625,576.10 |
| Other Receivables |
47,725,409.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
972,113,367.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,570,725.77 |
| Total Current Assets |
3,496,366,502.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,001,251,376.05 |
| Under-construction Projects |
1,682,901,227.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
179,838,331.14 |
| R&D expenses |
860,931.86 |
| Goodwill |
979,530.93 |
| Long-Term Deferred and Prepaid Expenses |
34,249,682.15 |
| Deferred Income Tax Assets |
53,353,372.63 |
| Other Non-Current Assets |
65,649,048.29 |
| Sub-Total of Non-Current Assets |
5,031,571,025.28 |
| Total Assets |
8,527,937,527.87 |
| Short-Term Loans |
1,996,441,860.38 |
| Trading Financial liabilities |
-- |
| Notes Payable |
577,376,814.02 |
| Accounts Payable |
816,696,603.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
29,384,367.90 |
| Taxes Payable |
9,076,295.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,124,331.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
147,567,336.09 |
| Other Current Liabilities |
157,940,651.57 |
| Sub-Total of Current Liabilities |
3,829,591,657.21 |
| Long-term Loans |
904,400,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,576,010.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
978,570,002.66 |
| Total Liabilities |
4,808,161,659.87 |
| Paid-In Capital(Or Share Stock) |
1,401,544,698.00 |
| Capital Surplus |
1,641,443,324.34 |
| Surplus Reserve |
145,540,598.70 |
| LESS:Treasury Stock |
50,099,951.92 |
| Undistributed Profits |
579,159,771.32 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,719,775,868.00 |
| Owner's Equity（Stockholder's Equity） |
3,719,775,868.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,527,937,527.87 |
